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Cytomorphologic Features of
Metastatic Urothelial Carcinoma
in Serous Effusions
Cheng Cheng Huang, M.D., PH.D.,1 Anoja Attele, M.D.,1 and
Claire W. Michael, M.D.2*
Metastatic urothelial carcinoma (UC) to serous effusion (SE) is
extremely rare and its cytomorphological features have only
been described in case reports. In this study, we searched the pa-
thology database at University of Michigan for SEs due to meta-
static UC in the last 20 years. A total of 25 cases from 20 patients
with clinically and pathologically confirmed metastatic UC in SEs
were retrieved. The specimens consisted of 15 pleural, 8 perito-
neal, and 2 pericardial effusions. Smears were reviewed and eval-
uated for the following features: cellularity, single cells, cell clus-
ters or short cords, cell wrapping, ‘‘windows’’ between the cells,
two-tone cytoplasm, cytoplasmic vacuoles, signet ring cells, nu-
clear to cytoplasmic (N/C) ratio, nuclear hyperchromasia, irregu-
lar nuclear membrane, nuclear centricity, double or multiple
nuclei, nucleoli, anaplastic cells and mitosis. Our results showed
that UC manifested in SEs predominantly as a single cell popula-
tion with or without clusters or short cords, and frequently exhib-
ited the ‘‘cell wrapping’’ of two or more cells. Individual UC cell
in SEs exhibited nuclear enlargement with increased N/C ratio,
irregular nuclear membranes, hyperchromatic coarse chromatin
and frequently prominent nucleoli. Double or multinucleated cells,
cells with vacuolated cytoplasm or signet ring appearance were
also frequently present. Our results demonstrated that while
certain features could suggest the diagnosis of UC, the cytomor-
phological features are not specific and often overlap with those
of reactive mesothelium, mesothelioma, metastatic adenocarci-
noma, or squamous cell carcinoma in SEs. Accurate diagnosis of
UC rests on the combination of clinical history, cytomorphologic
features and appropriate immunohistochemical panel. Diagn.
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Urothelial carcinoma (UC) of the bladder is the fifth most
common carcinoma in the United States.1 Approximately
5% of patients with bladder cancer present with de novo
metastatic disease at the time of the diagnosis, and an
additional 50% who are originally diagnosed with mus-
cle-invasive disease will develop a recurrence.2 UC usu-
ally disseminates through direct extension. The common
sites of the metastasis of UC of the bladder include lymph
node, bone, lung, liver, and adrenal gland.3 Metastasis of
the bladder UC to peritoneum and pleura accounts for 16
and 11% of the total bladder UC metastasis, respectively.4
The upper tract UC accounts for 5% of the total UC5 and
contributes 19 and 15% of metastasis to peritoneum and
pleura, respectively.6 Involvement of the peritoneum and
pleura by UC are commonly associated with widely
spread metastasis to other organs. However, SE as the ini-
tial solitary site of metastasis of UC has also been
reported.7
Cytological features of UC in pleural and peritoneal
fluid were to date described only in case reports.8–10
In this study, we report the cytomorphological features
of UC in 25 SEs and discuss the relevant differential
diagnoses.
Materials and Methods
A total of 25 specimens consisting of 15 pleural, 8 perito-
neal, 2 pericardial fluids from 20 patients were retrieved
from the pathology database at University of Michigan
during the period 1990 through 2011. All relevant clinical
information was obtained from the patients’ medical
records. For each specimen, two air-dried and Diff-Quik
stained smears, two fixed and Papanicolaou-stained
smears and a cell block were prepared. In bloody or low
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cellular samples, a ThinPrep was also prepared. The
smears, Hematoxylin and Eosin-stained cell blocks sec-
tions and relevant immunohistochemical stains (available
in 18 cases from 13 patients) were reviewed. The smears
were evaluated for the following features: cellularity,
single cells, cell clusters or short cords, cell wrapping,
‘‘windows’’ between the cells, two-tone cytoplasm, cyto-
plasmic vacuoles, signet ring cells, N/C ratio, nuclear
hyperchromasia, irregular nuclear membrane, nuclear cen-
tricity, double or multiple nuclei, nucleoli, anaplastic cells
and mitosis. A semiquantitative method was used to quan-
titate each of the cytomorphological features. In general,
a feature is considered as high (3+) when easily detected
at 103 magnification, moderate (2+) when detected at
203 or low (1+) when only detected at 403 magnifica-
tion. All the cases were separately reviewed by the three
authors. Discrepant cases were reviewed by two of the
authors including the senior pathologist (CWM) to
achieve consensus.
Results
The 25 cases of SEs with metastatic UC were retrieved
from 20 patients (15 males and 5 females) with age rang-
ing from 29 to 84 (mean 63.5) years old at time of pre-
sentation with the malignant SEs (Table I). The malignant
effusions consisted of 15 pleural fluids (60%), 8 perito-
neal fluids (32%), and 2 pericardial fluids (8%). UC origi-
nated from the urinary bladder and renal pelvis consti-
tuted 90 and 10% of metastatic UC in the fluids, respec-
tively. The interval between the initial diagnoses of UC to
the presentation with malignant effusion ranged between
1 and 228 months. More than half of the patients (11
cases, 55%) presented with the effusion within 1 year
after the initial diagnosis of the primary cancer. Bone,
lung, and liver were the most common metastatic sites
other than the pleural and peritoneal cavities. UC metasta-
sis to brain or pancreas occurred less frequently.
The cytomorphological features of the UC in SE are
summarized in Table II. The cellularity of the effusions
varied widely among all three serous cavities. The smears
presented with a predominantly singly dispersed cell pat-
tern in all 25 cases. A pattern of mixed single cells and
cell clusters was seen in 10 cases (40%). The cell clusters
were easily recognizable even in low magnification and
consisted of 10–20 cells each (Fig. 1). Occasional cyto-
plasmic vacuoles were noted within the cell clusters.
Short cords, defined as three to six cells forming a row,
were identified in 8 cases (32%) (Fig. 2). The short cords
were commonly appreciated at high-power magnification.
The cell clusters and the short cords usually coexisted in
the same specimen. ‘‘Cell wrapping,’’ defined in this study
as a tumor cell partially or completely wrapped by one or
more tumor cells with the nuclei molded in a crescent
form around the cytoplasm of the central cell, was identi-
fied in 12 cases (48%) (Fig. 3). When present, cell wrap-
ping was frequent and easily identified at low magnifica-
tion. The ‘‘windows’’ between the UC cells (Fig. 4) were
only seen in two cases (8%).
The UC cells (Fig. 4) exhibited high N/C ratio with,
central or eccentric nuclei. The nuclei were usually round,
oval or convoluted. Hyperchromasia, chromatin clumping,
irregular nuclear membranes, and enlarged nucleoli were
identified in the majority of cases. Binucleated or multi-
nucleated malignant cells were identified in 60 and 28%
of the specimen, respectively (Fig. 5). Cytoplasmic
Table I. Clinical and Pathological Data
Patient Age/sex
Fluid
source Primary
Interval to
metastasis
Metastasis
to other sites
1 71/F pleural bladder 1 pancreas
2 49/F pleural bladder 9 ND
3 72/M peritoneal bladder 7 Lung
4 77/M peritoneal kidney 26 Bone
5 57/F pleural bladder 11 Lung, liver
6 29/F pericardial kidney 2 ND
7 79/M pleural bladder 91 Bone
8 61/M Pleural bladder 13 Bone, lung, liver
9 84/M pleural bladder 43 Bone
10 77/M pleural bladder 9 ND
11 74/M pleural bladder 10 Lung
12 56/M pleural bladder 9 ND
13 69/M pleural bladder 228 Lung, liver
14 49/M peritoneal bladder 7 ND
15 43/M peritoneal bladder 12 Liver
16 67/F pleural bladder 13 Brain
17 70/M peritoneal bladder 30 Liver
18 61/M peritoneal bladder 8 Bone, liver
19 62/M peritoneal bladder NA NA
20 81/M pleural bladder NA NA
Month(s) is used for ‘‘interval to metastasis.’’ ND, not detected; NA, not
available.
Table II. Cytological Features of Urothelial Carcinoma in Serous Fluid
Number of cases (%)a
3+ 2+ 1+ 0
Smear patterns
Cellularity 9 (36) 5 (20) 11 (44) 0 (0)
Single cell 13 (52) 5 (20) 7 (28) 0 (0)
Cell clusters 3 (12) 4 (16) 3 (12) 15 (60)
Short cords 0 (0) 1 (4) 7 (28) 17 (68)
Cell wrapping 2 (8) 4 (16) 6 (24) 13 (52)
Cell windows 0 (0) 2 (8) 0 (0) 23 (92)
Cytological features
Two-tone cytoplasm 0 (0) 0 (0) 6 (24) 19 (76)
Cytoplasm vacuoles 4 (16) 3 (12) 5 (20) 13 (52)
N/C ratio 8 (32) 16 (64) 1 (4) 0 (0)
Nuclear hyperchromasia 5 (20) 9 (36) 5 (20) 6 (24)
Irregular nuclear membrane 1 (4) 10 (40) 10 (40) 4 (16)
Centric nuclei 6 (24) 7 (28) 11 (44) 1 (4)
Eccentric nuclei 1 (4) 11 (44) 7 (28) 6 (24)
Nucleoli 5 (20) 8 (32) 12 (48) 0 (0)
Double nuclei 2 (8) 2 (8) 11 (44) 10 (40)
Multiple nuclei 3 (12) 1 (4) 3 (12) 18 (72)
Signet ring cells 1 (4) 2 (8) 7 (28) 15 (60)
Anaplastic cells 0 (0) 2 (8) 10 (40) 13 (52)
Mitosis 0 (0) 2 (8) 2 (8) 21 (84)
aTotal case number is 25.
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vacuoles, both fine and large in size, were identified in
48% of the specimens (Fig. 6). Signet ring cells were
identified in 40% of the specimens (Fig. 6). Small number
of cells exhibiting two-tone cytoplasm was seen in 24%
of the specimens (Fig. 3, insert). Anaplastic tumor cells
(Fig. 5, insert) and mitotic figures (Fig. 3) were identified
in 12 cases (48%) and 4 cases (16%), respectively. Multi-
ple specimens retrieved from the same patient were mor-
phologically similar.
Various panels of immunohistochemical staining were
performed on the sections of cell blocks from 18 speci-
mens (13 patients). The tumor cells stained positively for
CK7, CK20 or high molecular weight keratin (HMWK)
in 11/12, 10/12, or 4/4 of the patients, respectively. The
tumor cells were negative for WT-1, calretinin or CD68
in all the cases stained (data not shown).
Discussion
Malignant SE is usually a manifestation of disseminated
and advanced stages of malignancy. Neoplasms of lung,
breast, ovary, and lymphoma constitute >75% of malig-
nant pleural effusions.11 The direct and/or indirect malig-
nant seeding of breast, ovarian, endometrial, gastric, colo-
nic, and pancreatic carcinomas contribute up to 80% of
malignant peritoneal effusions.4 SE usually occurs as
early as one to several months after the diagnosis of the
primary cancer. Occasionally, it can be the first manifesta-
tion of the disease before the diagnosis of the primary
malignancy. Metastasis of UC to the pleural or peritoneal
cavities is not common. In our institution, where 120 cys-
Fig. 1. Cell clusters consisting of 10–20 tumor cells each are easily rec-
ognizable in low-power magnification. Occasional cytoplasmic vacuoles
and signet ring cells are noted. Papanicolaou stains 3400. [Color
figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
Fig. 2. The short cords consist of three to six cells forming a row with
window-like spaces. Diff-Quik (left panel) and Papanicolaou (middle
and right panels) stains 3600. [Color figure can be viewed in the online
issue, which is available at wileyonlinelibrary.com.]
Fig. 3. UC cells show ‘‘cell wrapping’’ and mitotic activity. Diff-Quik
stain 3600. Some cells exhibit two-tone cytoplasm (insert, Diff-Quik
stain 31,000). [Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
Fig. 4. UC cells occasionally exhibit ‘‘window-like’’ arrangement
between the cells, increased N/C ratio, enlarged nuclei, irregular nuclear
membrane, hyperchromatic clumped nuclear chromatin, and one to three
nucleoli. Papanicolaou stain 3600. [Color figure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
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tectomies for UC are performed annually, a search of our
files during the last 20 years resulted in 25 fluids only
from 20 patients. In this study, a urinary bladder carci-
noma contributed 90% of the malignant effusions and the
UC of the renal pelvis contributed the remaining 10%.
More than half of the malignant effusions (11/18 cases) in
this study occurred within 1 year after the primary diag-
nosis, which supports the aggressive nature of those UCs.
The bone, lung and liver were the most common sites of
UC metastasis. The pattern of metastasis to other organs
in our study is consistent with those previously
reported.3,4
Single tumor cells, with or without clusters or short
cords, along with the ‘‘cell wrapping’’ were the main
cytological patterns observed in our study. On the individ-
ual cellular level, the characteristic features were nuclear
enlargement with increased N/C ratio, irregular nuclear
membrane, and hyperchromasia with coarse chromatin
and frequent prominent nucleoli. Double or multiple
nuclei were also frequently identified. Tumor cells with
vacuolated cytoplasm or signet ring cells were very com-
mon. Cytoplasmic inclusions or cercaria-like cells, fea-
tures frequently reported in smear preparations from fine
needle aspiration of metastatic UC,8,12,13 were not identi-
fied in this study (data not shown). The presence of high
number of mitotic figures and anaplastic tumor cells in
this study supports the high grade status of these meta-
static UCs.
The main differential diagnosis of UC in SEs includes
reactive mesothelial cells (RM), malignant mesothelioma
(MM), metastatic adenocarcinomas (ADC), and metastatic
poorly differentiated squamous cell carcinoma (PDSCC).
The Key features used in the differential diagnosis are
summarized in Table III.14 RM can present with moderate
to high cellularity in the benign effusion. They mainly
present as numerous single cells with variable number of
small clusters. RM can exhibit significant nuclear atypia
with nuclear enlargement, coarse chromatin, and irregular
nuclear contour or prominent nucleoli. However, the pres-
ence of dense two tone cytoplasm with a clear outer rim,
brush border, frequent ‘‘windows’’ between the mesothe-
lial cells and occasionally few submembranous glycogen
vacuoles are important cytological features in confirming
the mesothelial origin of these cells.11,15 RM cells typi-
cally form smaller, two-dimensional cellular clusters with
scalloped borders rather than three-dimensional cell clus-
ters. While the short cords in UC may mimic those of
mesothelial cells, they lack the classic mesothelial fea-
tures such as intercellular windows and cellular clasping
with cytoplasmic pinching.
MM commonly present with a pattern of single, nonco-
hesive tumor cells admixed with large cell clusters or
morule-like spheres in serous fluids. At low magnification,
the smear reveals a striking number of larger clusters of
mesothelioma cells with scalloped berry-like borders or
three dimensional (3D) spheres. The tumor cells are
markedly enlarged, and the morules or spheres are rela-
tively larger than those of UC. The pattern of ‘‘cell-
in-cell’’16 rather than that of ‘‘cell wrapping’’ favors the
diagnosis of mesothelioma. At the cellular level, in addi-
tion to the characteristic features of mesothelium such as
two tone cytoplasm, glycogen vacuoles and intercellular
windows, the single mesothelioma cells tend to be highly
variable in size ranging from size of a normal mesothelial
cell to a gigantic size approaching that of the small mor-
ules in the background. In contrast, UC cells tend to be
relatively uniform in size and shape except for the back-
ground scattered anaplastic cells. MM tend to have subtle
cytological atypia with low N/C ratio, relatively smooth
Fig. 5. Double or multiple nucleated cells are frequent. Diff-Quik 3400.
Anaplastic cells were not uncommon (insert, Diff-Quik 3600).
[Color figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
Fig. 6. Large or fine cytoplasmic vacuolation and signet ring cells are
common in some cases. Diff-Quik 3400. [Color figure can be viewed in
the online issue, which is available at wileyonlinelibrary.com.]
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nuclear contour and less nuclear hyperchromasia. Despite
the subtle atypia, nuclei of MM usually contain a promi-
nent nucleoli and frequently macronucleoli. In contrast,
UC nuclei exhibit at least moderate atypia. The nucleoli
are not as prominent and macronucleoli are rare. In con-
trast to the characteristic submembranous glycogen
vacuoles of MM, UC cells exhibited large and diffuse
cytoplasmic vacuoles mimicking adenocarcinoma in about
50% of the cases. The identification of double or multiple
nucleated cells does not help in the differential diagnosis
of UC, RM, and MM since these cells are frequently
noted in all three entities.
Tumors of glandular origin usually produce cellular
clusters with central lumina or pseudoacini in serous
fluid.17 The cytomorphology of cell aggregates, balloon-
like vacuolation and signet ring cells can be appreciated
in the fluids of both metastatic UC and ADC. Predomi-
nant single tumor cells and cell wrapping should raise the
possibility of UC.
Metastatic SCC is an exceedingly rare cause of malig-
nant SE. The common cytological features included dense
cytoplasm, cytoplasmic keratinization with occasionally
‘‘pearl’’ formation, well-defined cell borders and intercel-
lular bridging, and bizarre cell shapes such as tadpole
cells, spider cells etc.18 However, PDSCC is more diffi-
cult to differentiate from UC since it manifests as large
cell balls mimicking mesothelioma and adenocarcinomas.
Characteristically, small groups with attempt to form
pearls, dense refractile cytoplasm with well-defined
borders, and high degree of cellular pleomorphism are
seen. The cellular clusters when present in cell blocks
appear as large sheets with whorl pattern and well defined
cell borders. Intercellular junctions can be appreciated in
these fragments as well.
The immunohistochemical (IHC) staining plays an im-
portant role in the differential diagnosis of UC in the flu-
ids. As demonstrated in this study, UC is commonly posi-
tive for CK7, CK20, and HMWK. In addition to reaction
to mesothelial markers such as calretinin, WT-1 and D2-
40, RM, and MM also show strong cytoplasmic staining
with CK7. However, mesothelial cells are rarely reactive to
CK20. Calretinin is strongly positive in most of MM, dem-
onstrating a nuclear and cytoplasm staining pattern. In con-
trast, small numbers of adenocarcinomas show predomi-
nantly cytoplasm staining pattern.19 While positive staining
to EMA can separate UC for RM that is nonreactive, it is
important to remember that MM acquires a strong mem-
branous EMA staining. Therefore EMA should only be
used in the context of an IHC panel.20,21 Similarly, MOC-
31 and CEA stains should be used with caution and only
as part of an IHC panel since they positively react with
UC, ADC, and SCC. MOC-31 and CEA are positive in
100 and 83% of ADC and in 47 and 22% of SCC in SEs,
respectively.22,23 Morphologically, the SCC is the greatest
mimics of UC in the fluids. While HMWK, CK5/6, and
p63 have shown positive staining in 100, 89, and 80% of
SCCs, respectively,22,23 these markers commonly cross
react to both SCC and UC. The newer markers S100P and
Table III. Predominant Cytologic Features in UCC and its Differential Diagnosis14
Features UC RM MM ADC PDSCC
Cellularity +/++ ++ +++ +/++ +++
Cell variation (size and shape) /+ /+ +++ /+ /+
Clusters
Number /+ +/++ ++/+++ ++/+++ ++/+++
Architecture 3D 2D Morules 3D 3D
Border Scalloped Scalloped Scalloped Smooth Smooth
Cell pleomorphism ++ /+ +/++ +++ +++
Cell–cell arrangement Rare window
cell wrapping
Windows clasping
cell-in-cell
Windows clasping
cell-in-cell
cell-in-cell No windows cell
wrapping pearl
Cytoplasm
N/C ratio high low low high high
Two-tone cytoplasm + +++ +++  ++
Cytoplasmic vacuoles ++ /+ /+ ++/+++ /+
Signet ring cells +   ++ 
Submembranous vacuoles  +/++ +++  
Membrane brush border  ++ +++  
Nuclei
Enlarged in size ++ +/++ +++ ++/+++ +++
Nuclear centricity Variable Central Central Variable Central
Chromatin Coarse Vesicular Variable coarse coarse
Membrane irregularity ++ + +/++ +++ +++
Enlarged nucleoli ++ + +++ ++/+++ +++
Double nuclei ++ + +++ + +
Multiple nuclei + + +++ + +
Anaplastic cells +++ /+ + ++ ++
Mitotic figures + /+ +/++ ++/+++ ++/+++
Abbreviations: UC, urothelial carcinoma; RM, reactive mesothelium; MM, malignant mesothelioma; ADC, adenocarcinoma; PDSCC, poorly differenti-
ated squamous cell; Semi-quantitation: , none; +, low or few; ++, moderate or medium; +++, high or marked.
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GATA3 stain positively in 78 and 67% of UCs, respec-
tively. When S100P and p63 were combined, 95% of uro-
thelial carcinomas were stained by one or both markers.12
More importantly, GATA3 does not stain SCC24; and
therefore have a more promising role in differential of UC
and SCC in the fluids.
In conclusion, metastatic UC is rare in SE. The cyto-
morphological features of UC often overlap with those in
RM, MM, metastatic ADC, and metastatic PDSCC in se-
rous fluid. Familiarity with the cytomorphologic features
as well as the clinical history and utilization of immuno-
stains are very important to reach a definitive diagnosis of
UC in the fluid.
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